Rayont Inc Revenue Growth Rates (RAYT), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Rayont Inc   (RAYT)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

RAYT's Revenue Growth by Quarter and Year

Rayont Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RAYT Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter June -
3rd Quarter March 0.98
2nd Quarter December 1.42
1st Quarter September 1.37
FY 3.77

RAYTs Annual Revenue
Rayont Inc 's Revenue in the fiscal year 2022 $ 2.84 millions
Rayont Inc 's Revenue in the fiscal year 2021 $ 2.97 millions
Rayont Inc 's Revenue in the fiscal year 2020 $ 0.19 millions
Rayont Inc 's Revenue in the fiscal year 2019 $ 0.00 millions
Rayont Inc 's Revenue in the fiscal year 2018 $ 0.02 millions




RAYT Revenue third quarter 2023 Y/Y Growth Comment
Rayont Inc achieved in the third quarter 2023, above Company average Revenue surge of 113.13% year on year, to $ 0.98 millions.

According to the results reported in the third quarter 2023, Rayont Inc achieved the best Revenue growth in Healthcare Facilities industry. While Rayont Inc ' s Revenue doubling of 113.13% ranks overall at the positon no. 258 in the third quarter 2023.


RAYT Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
4th Quarter June - 110.42 % - -
3rd Quarter March 113.13 % -51.58 % 115.91 % -
2nd Quarter December 111.94 % 45.65 % 15 % -
1st Quarter September 98.55 % -2.82 % - -
FY   - 8.85 % 209.52 % -

Financial Statements
Rayont Inc 's third quarter 2023 Revenue $ 0.98 millions RAYT's Income Statement
Rayont Inc 's third quarter 2022 Revenue $ 0.46 millions Quarterly RAYT's Income Statement


RAYT Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
4th Quarter June - 119.57 % -49.47 % -
3rd Quarter March -30.96 % -31.34 % 106.52 % 10 %
2nd Quarter December 3.65 % -2.9 % -35.21 % -
1st Quarter September 35.64 % 43.75 % - -
FY (Year on Year)   - 8.85 % 209.52 % -


Back to RAYT Growth rate Comparisons >> Back to RAYT Growth rate Comparisons >>


Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #1
Healthcare Sector #79
Overall #258

Revenue Y/Y Growth Statistics
High Average Low
272.02 % 15.88 % -100 %
(Jun 30 2022)   (Sep 30 2017)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #1
Healthcare Sector #79
Overall #258
Revenue Y/Y Growth Statistics
High Average Low
272.02 % 15.88 % -100 %
(Jun 30 2022)   (Sep 30 2017)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Rayont Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
24228.87 % 1603.09 % -100 %
(Dec 31 2016)  


RAYT's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Rayont Inc disclosed fall in Revenue from the second quarter by -30.96% to $ 0.98 millions, from $ 1.42 millions achived in the previous reporting period.

But that's not important problem, as Rayont Inc 's Revenue generally seem to plunge in this quarter.

Within Healthcare Facilities industry 43 other companies have achieved higher Revenue quarter on quarter growth. While Rayont Inc 's Revenue growth quarter on quarter, overall rank is 3748.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #44
Healthcare Sector #575
Overall #3748
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #44
Healthcare Sector #575
Overall #3748
Revenue Q/Q Growth Statistics
High Average Low
24228.87 % 1603.09 % -100 %
(Dec 31 2016)  


RAYT's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Rayont Inc disclosed fall in Revenue from the second quarter by -30.96% to $ 0.98 millions, from $ 1.42 millions achived in the previous reporting period.

But that's not important problem, as Rayont Inc 's Revenue generally seem to plunge in this quarter.

Within Healthcare Facilities industry 43 other companies have achieved higher Revenue quarter on quarter growth. While Rayont Inc 's Revenue growth quarter on quarter, overall rank is 3748.


Rayont Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)		 12 Months Ending
(Mar 31 2022)
Cumulative Revenue 12 Months Ending $ 4.78 $ 4.27 $ 3.52 $ 2.84 $ 2.31
Y / Y Revenue Growth (TTM) 106.9 % 52.47 % 36.39 % 8.89 % 8.74 %
Year on Year Revenue Growth Overall Ranking # 363 # 195 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 12.09 % 21.16 % 23.99 % 22.87 % -17.4 %
Seq. Revenue Growth (TTM) Overall Ranking # 2652 # 818 # 0 # 0 # 577


Cumulative Revenue growth Comment
Rayont Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 106.9% year on year, to $ 5 millions if the fiscal year would have ended in Mar 31 2023.
Rayont Inc 's trailing twelve months Revenue growth was higher than company's average 45.94% and higher than 52.47% growth in Dec 31 2022.
But from twelve months ended Dec 31 2022 rise was beneth at 12.09 % from $4.27 millions achieved in the period from Dec 31 2022 to Mar 31 2022.
We witness drop-off happening, more obvious observing the When you usual Q/Q TTM historic rise that is stronger at45.94%.
The momentum is even more impressive from twelve months ended Dec 31 2022 exhibited at 12.09 % increase from $4.27 millions in the period from Dec 31 2022 to Mar 31 2022.

In the Healthcare sector 95 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 195 to 363.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 35
Healthcare Sector # 96
Overall # 363

Revenue TTM Y/Y Growth Statistics
High Average Low
77.9 %
 45.94 %
-48.48 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 35
Sector # 371
S&P 500 # 2652
Cumulative Revenue growth Comment
Rayont Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 106.9% year on year, to $ 5 millions if the fiscal year would have ended in Mar 31 2023.
Rayont Inc 's trailing twelve months Revenue growth was higher than company's average 45.94% and higher than 52.47% growth in Dec 31 2022.
But from twelve months ended Dec 31 2022 rise was beneth at 12.09 % from $4.27 millions achieved in the period from Dec 31 2022 to Mar 31 2022.
We witness drop-off happening, more obvious observing the When you usual Q/Q TTM historic rise that is stronger at45.94%.
The momentum is even more impressive from twelve months ended Dec 31 2022 exhibited at 12.09 % increase from $4.27 millions in the period from Dec 31 2022 to Mar 31 2022.

In the Healthcare sector 95 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 195 to 363.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 35
Healthcare Sector # 96
Overall # 363

Revenue TTM Y/Y Growth Statistics
High Average Low
77.9 %
45.94 %
-48.48 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 35
Sector # 371
S&P 500 # 2652




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RAYT's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Mar 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2023
Uniqure N v 197.15%$ 197.154 millions
Roivant Sciences Ltd 196.82%$ 196.823 millions
Beam Therapeutics Inc 187.10%$ 187.097 millions
Aclarion Inc 182.18%$ 182.185 millions
Motus Gi Holdings Inc 180.00%$ 180.000 millions
Intra cellular Therapies Inc 172.33%$ 172.334 millions
Inovio Pharmaceuticals Inc 167.25%$ 167.251 millions
Precision Biosciences Inc164.70%$ 164.697 millions
Sera Prognostics Inc 163.16%$ 163.158 millions
Transmedics Group Inc 161.68%$ 161.675 millions
Cytomx Therapeutics Inc 159.94%$ 159.945 millions
Bionik Laboratories Corp 158.15%$ 158.153 millions
Whitehawk Therapeutics Inc 154.31%$ 154.313 millions
Quantum Cyber N v 148.70%$ 148.699 millions
Impel Pharmaceuticals Inc 148.55%$ 148.550 millions
Mirum Pharmaceuticals Inc 145.10%$ 145.098 millions
Eton Pharmaceuticals Inc 143.75%$ 143.750 millions
Intelligent Bio Solutions Inc 137.43%$ 137.433 millions
Lucid Diagnostics Inc 135.98%$ 135.979 millions
Orasure Technologies Inc128.87%$ 128.873 millions
Recursion Pharmaceuticals Inc 127.53%$ 127.527 millions
Petvivo Holdings Inc 126.47%$ 126.468 millions
Tscan Therapeutics Inc 125.19%$ 125.190 millions
Bolt Biotherapeutics Inc 124.60%$ 124.600 millions
Macrogenics Inc 120.66%$ 120.665 millions
Hookipa Pharma inc 119.79%$ 119.792 millions
Northwest Biotherapeutics Inc118.36%$ 118.362 millions
Agile Therapeutics Inc116.52%$ 116.525 millions
Sutro Biopharma Inc 114.92%$ 114.923 millions
Invo Fertility Inc 114.04%$ 114.040 millions


About Rayont Inc Revenue Growth Rates (RAYT), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Rayont Inc (CIK 1539778).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-23-016818
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Rayont Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.